ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. March 13, 2025
Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity March 6, 2025
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01 March 6, 2025
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark March 6, 2025